Literature DB >> 2930566

Cremophor EL, a widely used parenteral vehicle, is a potent inhibitor of protein kinase C.

F K Zhao1, L F Chuang, M Israel, R Y Chuang.   

Abstract

Cremophor EL, a castor oil derivative, has been considered a non-toxic solubilizer for lipophilic drugs and vitamins. Protein kinase C, a phospholipid/Ca++-dependent protein kinase, is known to phosphorylate, in response to extracellular stimuli, a variety of proteins for cellular functions. The present study shows that Cremophor EL selectively inhibits the activity of protein kinase C in vitro. The potency of this selective inhibition is greater than that of other protein kinase C-specific inhibitor thus far reported. Cremophor EL acts primarily on the enzyme activator diacylglycerol (or the phorbol ester) and prevents the latter from both interacting with the phospholipid and binding to protein kinase C. This is the first report of a significant biological activity induced by this widely used substituted castor oil solubilizer.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2930566     DOI: 10.1016/0006-291x(89)92260-2

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

Review 1.  Role of formulation vehicles in taxane pharmacology.

Authors:  L van Zuylen; J Verweij; A Sparreboom
Journal:  Invest New Drugs       Date:  2001-05       Impact factor: 3.850

2.  Nicotine-induced release of noradrenaline and neuropeptide Y in guinea-pig heart: role of calcium channels and protein kinase C.

Authors:  M Haass; G Richardt; T Brenn; E Schömig; A Schömig
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-11       Impact factor: 3.000

3.  Signal transduction of a tissue interaction during embryonic heart development.

Authors:  R B Runyan; J D Potts; R V Sharma; C P Loeber; J J Chiang; R C Bhalla
Journal:  Cell Regul       Date:  1990-02

4.  Attaching the NorA Efflux Pump Inhibitor INF55 to Methylene Blue Enhances Antimicrobial Photodynamic Inactivation of Methicillin-Resistant Staphylococcus aureus in Vitro and in Vivo.

Authors:  Ardeshir Rineh; Naveen K Dolla; Anthony R Ball; Maria Magana; John B Bremner; Michael R Hamblin; George P Tegos; Michael J Kelso
Journal:  ACS Infect Dis       Date:  2017-08-17       Impact factor: 5.084

5.  Stable synthetic bacteriochlorins for photodynamic therapy: role of dicyano peripheral groups, central metal substitution (2H, Zn, Pd), and Cremophor EL delivery.

Authors:  Ying-Ying Huang; Thiagarajan Balasubramanian; Eunkyung Yang; Dianzhong Luo; James R Diers; David F Bocian; Jonathan S Lindsey; Dewey Holten; Michael R Hamblin
Journal:  ChemMedChem       Date:  2012-10-12       Impact factor: 3.466

6.  Cellular signaling by cyclosporine A in contractile cells: interactions with atrial natriuretic peptide.

Authors:  H Meyer-Lehnert; D Bokemeyer; U Friedrichs; S Drechsler; H J Kramer
Journal:  Clin Investig       Date:  1993-02

7.  Effects of polysorbates and Cremophor EL on vascular responses in rat aorta.

Authors:  H Zengil; U Hodoğlugil; Z Güney
Journal:  Experientia       Date:  1995-11-15

8.  The polyoxyethylene castor oil Cremophor EL modifies multidrug resistance.

Authors:  G J Schuurhuis; H J Broxterman; H M Pinedo; T H van Heijningen; C K van Kalken; J B Vermorken; E C Spoelstra; J Lankelma
Journal:  Br J Cancer       Date:  1990-10       Impact factor: 7.640

9.  MEK1/2 inhibitor U0126, but not nimodipine, reduces upregulation of cerebrovascular contractile receptors after subarachnoid haemorrhage in rats.

Authors:  Simon T Christensen; Sara E Johansson; Aneta Radziwon-Balicka; Karin Warfvinge; Kristian A Haanes; Lars Edvinsson
Journal:  PLoS One       Date:  2019-04-12       Impact factor: 3.240

10.  Liquid chromatography/tandem mass spectrometry method for quantitation of cremophor el and its applications.

Authors:  V Vijaya Bhaskar; Anil Middha
Journal:  Int J Anal Chem       Date:  2013-07-28       Impact factor: 1.885

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.